Article Versions Notes

Bukhari N, Alshangiti A, Tashkandi E, Algarni M, Al-Shamsi HO, Al-Khallaf H. Fluoropyrimidine-Induced Severe Toxicities Associated with Rare DPYD Polymorphisms: Case Series from Saudi Arabia and a Review of the Literature. Clinics and Practice. 2021; 11(3):467-471. https://doi.org/10.3390/clinpract11030062

Bukhari, Nedal, Abdulraheem Alshangiti, Emad Tashkandi, Mohammed Algarni, Humaid O. Al-Shamsi, and Hamoud Al-Khallaf. 2021. "Fluoropyrimidine-Induced Severe Toxicities Associated with Rare DPYD Polymorphisms: Case Series from Saudi Arabia and a Review of the Literature" Clinics and Practice 11, no. 3: 467-471. https://doi.org/10.3390/clinpract11030062

Bukhari, N., Alshangiti, A., Tashkandi, E., Algarni, M., Al-Shamsi, H. O., & Al-Khallaf, H. (2021). Fluoropyrimidine-Induced Severe Toxicities Associated with Rare DPYD Polymorphisms: Case Series from Saudi Arabia and a Review of the Literature. Clinics and Practice, 11(3), 467-471. https://doi.org/10.3390/clinpract11030062